Literature DB >> 6456150

Striatal ganglioside levels in the rat following kainic acid lesions: comparison with Huntington's disease.

M R Higatsberger, G Sperk, H Bernheimer, K S Shannak, O Hornykiewicz.   

Abstract

Ganglioside and DNA levels were estimated in the striatum of rats 10 days and 6 weeks after lesioning by intrastriatal injection of kainic acid. There was a moderate, 21-24% decrease of the ganglioside concentration per unit protein on the side of the lesion, which can be ascribed to the loss of the intrinsic striatal neurons following the injection of kainic acid. On the other hand, there was a 131 and 60% increase of DNA per unit protein in the kainate injected side 10 days and 6 weeks after the lesions, respectively; these changes apparently reflected the gliotic reaction brought about by the neurotoxin. Qualitatively similar findings--a decrease of ganglioside and an increase of DNA levels per unit protein--were also found in the brain of patients with Huntington's disease; however, as compared with the corresponding control material, the decrease of the ganglioside concentration was more pronounced in the striatum of Huntington's disease (by 38% in the caudate nucleus and by 46% in the putamen) than in the kainate lesioned rat striatum. This difference could be due to the different proportions of the intrinsic and extrinsic neuronal plasma membranes in the striatum of the two species; however, the possibility of a more generalized affection of neuronal plasma membranes in Huntington's disease may also be envisaged.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456150     DOI: 10.1007/bf00238752

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  31 in total

1.  Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea.

Authors:  J T Coyle; R Schwarcz
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

2.  Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids.

Authors:  E G McGeer; P L McGeer
Journal:  Nature       Date:  1976-10-07       Impact factor: 49.962

3.  CONGENITAL AMAUROTIC IDIOCY.

Authors:  B HAGBERG; G HULTQUIST; R OHMAN; L SVENNERHOLM
Journal:  Acta Paediatr Scand       Date:  1965-03

4.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

5.  Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients.

Authors:  K G Lloyd; I J Farley; J H Deck; O Hornykiewicz
Journal:  Adv Biochem Psychopharmacol       Date:  1974

6.  Gangliosides in isolated neurons and glial cells.

Authors:  D M Derry; L S Wolfe
Journal:  Science       Date:  1967-12-15       Impact factor: 47.728

7.  [Gangliosides in the cerebrospinal fluid and the Tay-Sachs disease].

Authors:  H Bernheimer
Journal:  Klin Wochenschr       Date:  1968-03-01

8.  Gangliosides of the neuron: localization and origin.

Authors:  R W Ledeen; J A Skrivanek; L J Tirri; R K Margolis; R U Margolis
Journal:  Adv Exp Med Biol       Date:  1976       Impact factor: 2.622

9.  Chemical studies on Jakob-Creutzfeldt disease.

Authors:  K Suzuki; G Chen
Journal:  J Neuropathol Exp Neurol       Date:  1966-07       Impact factor: 3.685

10.  Antiserum to brain gangliosides produces recurrent epileptiform activity.

Authors:  S E Karpiak; L Graf; M M Rapport
Journal:  Science       Date:  1976-11-12       Impact factor: 47.728

View more
  7 in total

Review 1.  Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases.

Authors:  Sara Grassi; Paola Giussani; Laura Mauri; Simona Prioni; Sandro Sonnino; Alessandro Prinetti
Journal:  J Lipid Res       Date:  2019-12-23       Impact factor: 5.922

Review 2.  Functional roles of gangliosides in neurodevelopment: an overview of recent advances.

Authors:  Robert K Yu; Yi-Tzang Tsai; Toshio Ariga
Journal:  Neurochem Res       Date:  2012-03-13       Impact factor: 3.996

Review 3.  Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice.

Authors:  Maria Dolores Ledesma; Alessandro Prinetti; Sandro Sonnino; Edward H Schuchman
Journal:  J Neurochem       Date:  2011-01-07       Impact factor: 5.372

Review 4.  Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.

Authors:  Marco Piccinini; Federica Scandroglio; Simona Prioni; Barbara Buccinnà; Nicoletta Loberto; Massimo Aureli; Vanna Chigorno; Elisa Lupino; Giovanni DeMarco; Annarosa Lomartire; Maria Teresa Rinaudo; Sandro Sonnino; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2010-02-03       Impact factor: 5.590

Review 5.  Lipid rafts in neurodegeneration and neuroprotection.

Authors:  Sandro Sonnino; Massimo Aureli; Sara Grassi; Laura Mauri; Simona Prioni; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2013-12-22       Impact factor: 5.590

6.  Glycolipid and ganglioside metabolism imbalances in Huntington's disease.

Authors:  Paula A Desplats; Christine A Denny; Kristi E Kass; Tim Gilmartin; Steven R Head; J Gregor Sutcliffe; Thomas N Seyfried; Elizabeth A Thomas
Journal:  Neurobiol Dis       Date:  2007-05-22       Impact factor: 5.996

7.  Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samples.

Authors:  Anastasios Mastrokolias; Rene Pool; Eleni Mina; Kristina M Hettne; Erik van Duijn; Roos C van der Mast; GertJan van Ommen; Peter A C 't Hoen; Cornelia Prehn; Jerzy Adamski; Willeke van Roon-Mom
Journal:  Metabolomics       Date:  2016-07-27       Impact factor: 4.290

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.